Skip to main content
Edwards Lifesciences Logo

The PASCAL Precision System

For degenerative mitral regurgitation

PASCAL Precision System background image
PASCAL Precision System background image
PASCAL Precision System background image

Meet the PASCAL
Precision System

The latest advancement from Edwards Lifesciences in transcatheter mitral therapies: The PASCAL Precision system

Meet the PASCAL Precision System Image
Meet the PASCAL Precision System Image
Meet the PASCAL Precision System Image

Discover the difference with the PASCAL implants

Designed for patient-focused care

PASCAL implant

Designed to reduce leaflet stress and increase open orifice area enabling low gradients

PASCAL Ace implant

Features a narrower design profile to help you optimize your treatment of degenerative mitral regurgitation

The PASCAL Ace image
The PASCAL Ace image
The PASCAL Ace image

The PASCAL Ace and PASCAL implants offer different designs with the same functionality.

Features

Treat your patients with degenerative mitral regurgitation with the latest transcatheter mitral innovation from Edwards Lifesciences

Features Image
Features Image
Features Image

Versatile implant configuration to navigate even challenging anatomies

Adapt to specific procedural and anatomical needs

Versatile implant configuration image
Versatile implant configuration image
Versatile implant configuration image

A wide range of paddle mobility and full elongation capabilities helps you maneuver, reconfigure, and retrieve the implant prior to release

Overview of the PASCAL Precision system

Advanced catheter technologies facilitate smooth navigation and implant deployment

Overview of the PASCAL Precision system image
Overview of the PASCAL Precision system image
Overview of the PASCAL Precision system image

Watch the PASCAL Precision system in action


Clinical evidence

CLASP IID Randomized Control Trial (RCT): The first and only RCT to directly compare two contemporary TEER therapy in patients with DMR.

CLASP IID Registry: A first-of-its-kind registry to evaluate the PASCAL system in DMR patients with complex anatomy.

CLASP: The first international, multicenter study to evaluate the safety and clinical outcomes of the PASCAL system.

Features Image
Features Image
Features Image

CLASP IID trial

The objective of this prospective, multicenter, randomized, controlled pivotal trial is to evaluate safety and effectiveness in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team.

1. Zahr F, et al. CLASP IID Randomized Trial and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation.  Presented at: TCT Annual Congress; 2024 Oct 30; Washington, DC.

The PASCAL Ace image
The PASCAL Ace image
The PASCAL Ace image

CLASP IID is a clinical trial from Edwards Lifesciences, reinforcing TEER as safe and effective for the treatment of patients with degenerative mitral regurgitation.

CLASP IID Registry

The objective of this prospective, multinational registry within the construct of the CLASP IID trial is to study significant symptomatic DMR patients with complex mitral valve anatomy deemed suitable for treatment with the PASCAL system.

1. Zahr F, et al. CLASP IID Randomized Trial and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation.  Presented at: TCT Annual Congress; 2024 Oct 30; Washington, DC.

CLASP study

The first, international multicenter study to evaluate the PASCAL system provides 3-year outcomes in patients with clinically significant MR. The results in this section are for the patients in this study with degenerative mitral regurgitation.

2. Spargias K et al.  Three-year outcomes for the transcatheter repair in patients with mitral regurgitation from the CLASP study.  CCI. 2023.

The PASCAL Ace image
The PASCAL Ace image
The PASCAL Ace image

Edwards Lifesciences is invested in building a robust body of clinical evidence, including 5 transcatheter mitral and tricuspid pivotal studies.

Sign up to learn more about the PASCAL Precision system and stay connected to Edwards Lifesciences

Fill in your information below to stay up to date on the latest advancements from

Edwards Lifesciences

If you would like further information about our privacy policy, please click here.

Would you like to opt-in to receive future email communications from Edwards Lifesciences?

This includes notification of future symposia, forums, conference activities, product updates, and educational events.